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Abstract: Skin permeation experiments have been broadly done since 1970s to 1980s as 
an evaluation method for transdermal drug delivery systems. In topically applied drug and 
cosmetic formulations, skin concentration of chemical compounds is more important than 
their skin permeations, because primary target site of the chemical compounds is skin 
surface or skin tissues. Furthermore, the direct pharmacological reaction of a metabolically 
stable drug that binds with specific receptors of known expression levels in an organ can be 
determined by Hill’s equation. Nevertheless, little investigation was carried out on the test 
method of skin concentration after topically application of chemical compounds. Recently 
we investigated an estimating method of skin concentration of the chemical compounds 
from their skin permeation profiles. In the study, we took care of “3Rs” issues for animal 
experiments. We have proposed an equation which was capable to estimate animal skin 
concentration from permeation profile through the artificial membrane (silicone membrane) 
and animal skin. This new approach may allow the skin concentration of a drug to be 
predicted using Fick’s second law of diffusion. The silicone membrane was found to be 
useful as an alternative membrane to animal skin for predicting skin concentration of 
chemical compounds, because an extremely excellent extrapolation to animal skin 
concentration was attained by calculation using the silicone membrane permeation data. In 
this chapter, we aimed to establish an accurate and convenient method for predicting the 
concentration profiles of drugs in the skin based on the skin permeation parameters of 
topically active drugs derived from steady-state skin permeation experiments. 
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1. Introduction 
Skin has been the focus as an application site of cosmetics and therapeutic drugs. Many transdermal 
drug delivery systems and topical drug formulations as well as cosmetics are on the market and 
determining the percutaneous absorption of drugs and cosmetic ingredients is important for develop 
good topical formulations; however, percutaneous absorption or skin permeation itself is not always 
important for topical formulations [1]. The concentration-dependent pharmacological activity of a 
metabolically stable drug that binds with specific receptors of known expression levels in an organ can 
be determined by Hill’s equation [2]. However, predicting the biological effects, either therapeutic or 
toxic, of a drug whose bio-disposition is complicated by metabolic events is based on its concentration 
at its site of action. The efficacy of topical drug delivery to the peripheral blood circulation is based on 
the concentration of the drug in the blood [3–5]. On the other hand, the blood concentration-time 
course can be predicted using skin permeation parameters, such as flux and permeability coefficients, 
obtained from in vitro skin permeation experiments [6–8]. 
Several techniques have been developed to measure the sectional skin concentrations of drugs, 
including suction blisters [9], punch and shave biopsies [10], heating [11], autoradiography [12], and 
tape-stripping [13–15]. However, measuring drug concentrations in small well-defined segments of the 
skin is very challenging. 
A few studies have determined drug levels in small segments of the skin using radiolabeled drugs. 
To our knowledge, no attempts have been made to predict drug concentrations in depth-dependent sections 
of the skin, except for one [16] in which already published results were fitted to selected models. 
Recently, criticism against animal experiments has greatly increased from the viewpoint of animal 
welfare. In the EU, animal experiments to the production and import of cosmetic formulations are 
banned from 2009 to 2013 [17–20]. Scientists have to be aware of the spirit of the 3Rs for animal 
experiments, where the 3Rs are “Reduction”, referring to methods that enable researchers to obtain 
comparable levels of information from fewer animals, or to obtain more information from the same 
number of animals, “Refinement” refers to methods that alleviate or minimize potential pain, suffering 
or distress, and enhance the welfare of the animals used, and “Replacement” refers to the preferred use of 
non-animal methods over animal methods whenever it is possible to achieve the same scientific aims. 
We therefore used silicone membrane as an alternative to skin membrane to determine the skin 
concentration of cosmetic ingredients or drugs, from the viewpoints of the great necessity of estimating 
their concentration in the skin in the development of cosmetics or topical formulations as well as 
animal experiment alternatives. Silicone membrane has been used as an alternative to skin membrane 
and the permeation of cosmetic ingredients and drugs through the silicone membranes was compared 
with that through animal skin [21–24]. Few experiments have been performed, however, on their skin 
or membrane concentration. In the present chapter, a method for estimating skin concentration was 
established using silicone membrane permeability. A series of parabens (methyl, ethyl, n-propyl,  
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n-butyl esters) were used as model penetrants, since they have very different lipophilicities (i.e.,  
n-octanol/water partition coefficient) in spite of having a similar molecular weight (152–194 Da).  
2. Theoretical  
2.1. One-Layered Diffusion Model  
2.1.1. Determination of Membrane Concentration 
The diffusion of chemical compounds in the membrane is expressed theoretically by Fick’s 2nd law 
of diffusion, డ஼డ௧ ൌ ܦ
డమ஼
డ௫మ , under the assumption that the membrane is a homogeneous single layer, 
where C is the penetrant concentration in the membrane at position, x, and time, t [25–27]. When a 
sink condition is assumed on the receiver side of the membrane, i.e., x = L, a set of initial conditions  
(C = 0 at t = 0 and 0 < x < L) and boundary conditions (C = KCv at x = 0 and C = 0 at x = L, where K is 
the partition coefficient of the penetrant from the vehicle to membrane and Cv is the penetrant 
concentration in the vehicle) are obtained (see Figure 1a). 
Figure 1. Schematic diagram of concentration-distance profile in one layered (a) and two 
layered (b) diffusion membrane models in membrane permeation experiments. Membrane 
thickness is L and Lsc + Lved for one- and two-layered diffusion membranes models, 
respectively. Cv is the donor concentration of parabens and K and Ksc are partition 
coefficients to membranes.  
  
Then, membrane concentration, C, and its steady-state level at an infinite time, Css, are expressed  
as follows [28]: 
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Further, the mean membrane concentration of penetrant,  and are obtained by integrating C in 
Equations (1) and (2) from x = 0 to L: 
 (3)
 (4)
As shown in Equation (4), the mean membrane concentration of the penetrant can be determined by 
K and Cv, not by D. Because Cv is a known parameter, a parameter, K, is the only determinant of the 
mean membrane concentration of the penetrant. 
2.1.2. Determination of Membrane Permeation 
Since the silicone membrane can be supposed to be homogenous in one layer, the permeation 
profiles of parabens throughout the membrane were analyzed using a one-layered diffusion model [29,30]. 
Under the initial and boundary conditions shown as above, the amount of drug permeating the unit area 
of the silicone membrane at time t, Q, can be represented as, 
 (5)
The partition parameter (KL) and diffusion parameter (D/L2) were obtained by curve fitting the 
obtained data to Equation (5) using the least squares method. In the calculation of D and K, the 
thickness of the silicone membrane was fixed at 68 m. Permeability coefficient, P, was calculated by 
an Equation, P	=	 KD
L
. 
Stripped hairless rat skin was treated as a homogeneous layer, the same as the silicone membrane. 
2.2. Two-Layered Diffusion Model 
2.2.1. Determination of Membrane Concentration Using Two-Layered Diffusion Model 
Figure 1b shows a typical two-layered diffusion model of skin. Penetrant concentration in the first 
layer of skin, the stratum corneum, Csc, and that in the 2nd layer, the viable epidermis and dermis of 
skin, Cved, can be expressed by Fick’s 2nd law of diffusion. Similarly, initial conditions and boundary 
conditions are represented. Boundary condition between the first and second layer is Cved = KscKvedCsc 
and DSC
dCSC
dx
	=	Dved dCveddx , where Ksc and Kved are partition coefficients of the penetrant from the vehicle 
to stratum corneum and to the viable epidermis and dermis, and Dsc and Dved are diffusion coefficients 
in the stratum corneum and viable epidermis and dermis, respectively. 
In the two-layered diffusion model, the overall permeability coefficient, Ptot, can be expressed  
by that in the stratum corneum, Psc, and in the viable epidermis and dermis, Pved, as follows,  
in Equation (6) [31]: 
 (6)
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In addition, the reciprocal of the permeability coefficient can be replaced with permeation resistant, 
R and the following equation can be derived, as Equation (7). 
 (7)
The permeation resistance of the penetrants can be represented as in the electric circuit. Two 
resistances, Rsc and Rved exist in the skin membrane, as shown in Figure 1b. The ratio of the Line 
segment ab against bc at the surface between the stratum corneum and viable epidermis, x = 0, should 
be the ratio of Rsc against Rved. Thus, the penetrant concentration at point b, Cb, can be represented by: 
 (8)
The amount of penetrant in the unit area of the stratum corneum, Msc, can be represented using 
Equation (8) as Equation (9). 
 (9)
Since the partition coefficient of the penetrant from the stratum corneum to the viable epidermis and 
dermis is represented as Ksc/Kved, the amount of penetrant in the unit area of the viable epidermis and 
dermis, Mved, can be represented as,  
 (10)
By summation of Equations (9) and (10), Mtot, the drug amount in the unit area of the skin can be 
represented as follows: 
 (11)
By dividing Mtot in Equation (11) by skin thickness, Ltot, the average drug concentration in the skin, 
, is  
 (12)
When resistances, R are changed to permeability coefficients, P, finally Equation (13) was derived, 
 (13)
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2.2.2. Determination of Membrane Permeation Using Two-Layered Diffusion Model  
Two diffusion coefficients, Dsc and Dved and two partition coefficients, Ksc and Kved were obtained 
by curve fitting the cumulative amount of parabens that permeated through the full-thickness skin and 
stripped skin to the theoretical values using the least squares method, where theoretical values were 
expressed by two diffusion equations (Fick’s 2nd law) showing the diffusion profiles in the stratum 
corneum and viable epidermis and dermis. Differential equations describing Fick’s 2nd law are  
as follows: 
 (14)
 (15)
Mathematical treatment for determining the skin permeation using two-layered diffusion model was 
the same as in our previous method [26]. 
2.3. Calculation of Permeation Parameters 
Generally, most resistance against drug permeation throughout hairless rat skin is in the stratum 
corneum [31]. Rat skin was also treated as a single-layered membrane, the same as the silicone 
membrane. Parameters D and K were calculated under the assumption that the stratum corneum is a 
homogeneous membrane with a thickness of 15 m. 
2.4. Calculation of Theoretical Membrane Concentration of Parabens 
The theoretical membrane concentration of parabens was calculated by Equation (6) and the  
K value obtained from the membrane permeation study.  
3. Materials and Methods 
3.1. Reagents and Materials 
Parabens:methyl paraben (MP), ethyl paraben (EP), n-propyl paraben (PP), n-butyl paraben (BP), 
were obtained from Tokyo Kasei Chemical Co., Ltd. (Tokyo, Japan). An esterase inhibitor, diisopropyl 
fluorophosphate (DFP), and a deproteinization agent, trichloroacetic acid (TCA), were obtained from 
Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Other reagents and solvents were liquid 
chromatograph and special grade chemicals. 
The silicone membrane (Dow Corning 7-4107) was a gift from Nagase & Co., Ltd. (Tokyo, Japan). 
3.2. Experimental Animals 
Male hairless rats (WBM/ILA-Ht, 230–280 g) were obtained from the Life Science Research 
Center, Josai University (Sakado, Saitama, Japan) or Ishikawa Experimental Animal Laboratories 
(Fukaya, Saitama, Japan). All animal experiments were performed according to the ethics committee 
of Josai University. 
 jijiji CCtdtdC ,1,, 1  
 jijijiji CCCxdxCd ,1,,122 ,
2
21  
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3.3. Membrane Permeation Experiments of Parabens 
The silicone membrane was set on a Franz-type diffusion cell (receiver cell volume: 6.0 mL, 
effective diffusion area: 1.77 cm2) using cyanoacrylate glue [19–22]. Phosphate-buffered saline  
(pH 7.4, PBS) was applied to the receiver cell and maintained at 32 C for 15 min. Aliquots (0.5 mL) 
of different concentrations of parabens (MP 10 mM, EP 5 mM, PP 1 mM, BP 0.5 mM) in PBS were 
applied to the donor cell to start the permeation experiment. The experimental setup is shown in Figure 2. 
The receiver solution was stirred on a magnetic stirrer with a bar, the experiment was performed at  
32 C. At predetermined intervals, 400 L of the receiver solution was sampled, and the same volume 
of PBS was added to the receiver cell to keep the volume constant. Paraben concentration was 
determined by HPLC.  
Figure 2. Schematic representation of permeation experiment using silicone membrane and 
hairless rat skin. 
 
Abdominal skin (full-thickness skin or stripped skin) was excised from hairless rats under 
pentobarbital (25 mg/kg, i.p.) anesthesia and debris and excess fat were trimmed off the excised skin. 
Stripped skin was made by tape-stripping the stratum corneum 20 times before excising from rats. The 
obtained skin piece was then set on the Franz-type diffusion cell, as above. DFP (2.7 mol/mL in PBS) 
was applied to the receiver cell for half an hour in order to inhibit esterase enzymes activity [12,24–26]. 
After rinsing off the reagent, paraben solution (0.5 mL) in PBS and DFP in PBS (0.54 mol/mL,  
6.0 mL) were added to the donor and receiver cells, respectively, to start the skin permeation 
experiment. Other procedures were as in the silicone membrane permeation experiments. 
3.4. Determination of Extraction Ratio of Parabens 
3.4.1. Silicone Membrane 
Silicone membrane was loaded with parabens in chloroform and dried. Fresh chloroform (1 mL) 
was then applied to the silicone membrane piece. After agitating for 15 min, the resulting chloroform 
was sampled and fresh chloroform was again added for the second extraction of parabens. Total 
Stirrer bar
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chloroform containing parabens was evaporated to dryness and the sample was reconstituted with  
1.0 mL acetonitrile. The sample was injected onto HPLC to determine the paraben concentration. The 
extraction ratio of parabens from silicone membrane was almost 1.0.  
3.4.2. Hairless Rat Skin 
Hairless rat skin was loaded with parabens in water, and the skin piece was minced with scissors 
and homogenized at 12,000 rpm using a homogenizer (Polytron PT-MR 3000; Kinematica Inc., Littau, 
Switzerland) for 5 min at 4 C. The homogenate was incubated for 1 h at 32 C. The same volume of 
16% TCA was added to the skin homogenate and agitated for 15 min. The supernatant after 
centrifugation (15,000 rpm, 5 min, 4 C) was injected onto HPLC. Parabens were extracted from the 
skin homogenate using chloroform, as in the silicone membrane experiment. The extraction ratio of 
parabens was almost 1.0. 
3.5. Determination of Paraben Concentration in Silicone Membrane and Hairless Rat Skin 
3.5.1. Silicone Membrane 
After the permeation experiment, the donor solution was removed and the silicone membrane was 
washed with PBS (1 mL). Chloroform (1 mL) was added to the silicone membrane in the Franz-type 
diffusion cell (permeation area: 1.77 cm2) and agitated for 15 min to extract parabens from the 
membrane. The subsequent procedure was as in Section 3.4. 
3.5.2. Hairless Rat Skin 
After the permeation experiment, the donor solution was removed and the stratum corneum side of 
hairless rat skin was washed two times with PBS (1 mL). The rat skin was taken from the diffusion 
cell, and the permeation area of the skin (1.77 cm2) was kept in a freezer (−15 C) before determining 
the skin concentration. This frozen skin was minced with scissors and PBS (1 mL) was added to 
homogenize the minced skin (12,000 rpm, 5 min, 4 C). The subsequent procedure was as in Section 3.4. 
3.6. Determination Methods of Parabens 
The same volume of acetonitrile containing an internal standard (another paraben) was added to the 
paraben samples. After slight mixing, the sample was injected onto HPLC. The HPLC system consists 
of a pump (LC-10AD; Shimadzu, Kyoto, Japan), Chromatopac (C-R6A; Shimadzu), UV detector 
(SPD-6A; Shimadzu), system controller (SCL-6B; Shimadzu) and an auto-injector (SIL-7A; 
Shimadzu). The column was LiChroCART®250-4 (KGaA·64271; Merck, Darmstadt, Germany) kept at 
40 C during the eluting mobile phase, 0.1% phosphoric acid:acetonitrile = 75:25 for MP and EP,  
0.1% phosphoric acid:acetonitrile = 55:45 for PP and BP. The flow rate was 1.0 mL/min. The injection 
volume was 20 L, and detection was performed at 260 nm. 
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4. Results and Discussions 
4.1. Partition Coefficient and Concentration of Parabens into and in the Silicone Membrane 
Since drug distribution in the skin membrane is a physical phenomenon, it can be evaluated using 
artificial membranes as well as animal skin. A silicone membrane was used in this experiment due to 
its cost and easy availability. 
The direct measurement of drug concentration in the membrane has several problems. Generally, 
only one data point is obtained from one membrane after drug application. In addition, controlling the 
removal of the drug formulation from the membrane surface is very difficult. Hard cleaning of the 
membrane surface decreases the membrane concentration, whereas inadequate cleaning may leave the 
drug formulation on the membrane. We first performed the membrane permeation experiment and 
permeation parameters were obtained. The membrane concentration can be calculated using the 
partition coefficient, K, of the applied drug from the vehicle to the membrane, as shown in Equation (6). 
Next, the calculated values were compared with the directly observed membrane concentration. The 
membrane was obtained after the membrane permeation experiments. 
Figure 3 shows the cumulative amount of parabens that permeated the silicone membrane.  
Figure 3a,b show raw and normalized data (raw data divided by application concentration of 
parabens), respectively. The permeation ratio of BP against the application amount was highest, 
followed by PP, EP and MP. The increase in the lipophilicity of parabens increased the permeability, as 
shown in Figure 3b. 
Figure 3. Time course of the cumulative amount of parabens that permeated the silicone 
membrane. (a) raw data; (b) normalized data. ●: 10 mM MP; ◊: 3 mM EP; ▲: 1 mM PP; 
□: 0.5 mM BP. Each data point represents the mean ± S.E. (n = 4–8). 
 
Generally, high permeability and solubility of chemicals through and in the membrane are observed 
when the solubility parameter of chemicals is close to that of membrane. The solubility parameter 
values of parabens were calculated by Feder’s equation. The solubility parameter of BP,  
10.9 (cal/cm3)1/2, is closest to that of the silicone membrane (7.3–7.5 (cal/cm3)1/2) among the parabens 
(MP: 11.5 (cal/cm3)1/2, EP: 11.3 (cal/cm3)1/2, PP: 11.1 (cal/cm3)1/2) used in this experiment. 
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Figure 4a,b show the observed concentration and normalized concentration corrected using the 
application concentration of parabens in the silicone membrane, respectively. Each concentration is 
that at the steady state after starting the permeation experiments. An increase in Ko/w of parabens 
increases the membrane concentration. 
Figure 4. Raw data (a) and normalized date [(silicone membrane concentration)/ 
(donor concentration)] (b) for steady-state silicone membrane concentration of parabens. 
Each column represents the mean ± S.E. (n = 4–8). 
 
Figure 5 shows the relationship between the theoretical and observed values of paraben 
concentration in the silicone membrane. This figure shows almost a 1:1 relationship between them, 
suggesting that the silicone membrane can be assumed to be one homogenous layer and that the 
membrane concentration of parabens can be theoretically determined by Cv and K. These results also 
suggest that the permeation experiment is useful to determine the membrane concentration. The figure 
also contains the permeation parameters of parabens in the legend. The permeation parameters were 
obtained by curve-fitting the permeation profiles to Fick’s law of diffusion using the nonlinear least 
squares method, under the assumption that the silicone membrane is one homogenous layer. The 
permeability coefficient, P, of MP and BP was lowest and highest among the parabens used in this 
experiment. The diffusion coefficient, D, of these parabens in the silicone membranes was not so 
different (only 2–3 times different), whereas partition coefficient, K, was very different among these 
parabens (26 times different between MP and BP). A very different permeability coefficient, P, is 
closely related to the K of parabens. Since the p-value of parabens throughout the silicone membrane 
was very high (about 10−5 cm/s), the permeation profiles can be evaluated in a short experimental 
period. The theoretical membrane concentration of parabens, calculated from the K-value was very 
close to the observed membrane concentration. 
  
a) Raw data b) Normalized data
M
em
br
an
e c
on
c.
 (
g/
m
L
)
M
em
br
an
e c
on
c.
/d
on
or
 c
on
c.
MP EP BPPP
0
100
200
300
400
500
0
1
2
3
4
MP EP BPPP
Pharmaceutics 2013, 5 644 
 
 
Figure 5. Relationship between theoretical and observed steady-state silicone membrane 
concentration of parabens. Normalized data were used (see Figure 4). One-layered diffusion 
membrane model was used to obtain theoretical steady-state membrane concentration of 
parabens. ●: 10 mM MP; ◊: 3 mM EP; ▲: 1 mM PP; □: 0.5 mM BP. The observed data 
represent the mean ± S.D. (n = 4–8). Almost 1:1 correlation was found. P values were  
listed below. 
Parabens P Value (×10−5 cm/s) 
MP 1.53 ± 0.102 
EP 3.47 ± 0.998 
PP 8.76 ± 2.18 
BP 16.1 ± 1.11 
 
 
 
 
 
 
 
 
 
4.2. Membrane Permeation and Concentration: Comparison between Silicone Membrane and Animal Skin 
The theoretical concentration of parabens in silicone membrane, which was calculated from 
partition coefficient, K, was close to the observed concentration. A similar trial was carried out for the 
paraben concentration in hairless rat skin. Partition and skin concentration of parabens in rat skin were 
compared to those in the silicone membrane. 
Figure 6 shows the cumulative amount of parabens that permeated the excised hairless rat skin. 
Figure 6a,b show the mean raw data and normalized permeation data. The latter was normalized by the 
application amount of parabens. The raw skin permeation data of parabens, as shown in Figure 6a, are 
similar to silicone membrane permeation; however, the permeability coefficient ratio of BP against MP 
in hairless rat skin was much larger than that in the silicone membrane. This may have been due to the 
different permeation pathways between the silicone membrane and rat skin. The silicone membrane is 
a homogeneous membrane, whereas hairless rat skin has appendages such as hair follicles as well as 
the stratum corneum pathway. Interestingly, BP permeation through the silicone membrane was highest 
in the normalized data (Figure 3b) among the parabens used in the present study, whereas PP 
permeation through rat skin was highest (Figure 6b). These data are probably due to similar solubility 
parameter of BP or PP to that of the silicone membrane or rat skin, respectively. 
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Figure 6. Time course of the cumulative amount of parabens that permeated hairless rat 
intact skin. (a) raw data; (b) normalized data. Symbols: ●: 10 mM MP; ◊: 3 mM EP;  
▲: 1 mM PP; □: 0.5 mM BP. Each data point represents the mean ± S.E. (n = 5–11). 
 
Figure 7a,b show the observed and normalized concentrations of parabens corrected using their 
application concentrations in hairless rat skin, respectively. Each paraben concentration in rat skin was 
that at the steady state after starting the skin permeation experiment. As in the silicone membrane, the 
increase in partition coefficient, K, of parabens increased the skin concentration. The increment, 
however, was marked in the silicone membrane concentration, not in rat skin, except MP. This is due to 
the similar solubility parameter of parabens to that in the silicone membrane. 
Figure 7. Raw data (a) and normalized data (b) [(skin concentration)/(donor concentration)] 
for steady-state hairless rat skin concentration of parabens. Each column represents the 
mean ± S.E. (n = 5–11).  
 
Figure 8 shows the relation between the theoretical and observed skin concentrations of parabens. 
Although no 1:1 relationship was observed, a linear relation was found. When skin permeation data of 
a series of compounds are obtained, the skin concentration of the compounds may be theoretically 
calculated. The figure also contains the obtained permeation parameters of parabens in the figure 
legend, under the assumption that the skin membrane is one homogenous layer. Compared to the 
silicone membrane, lower P and D and higher K were observed in the rat skin. Unfortunately, the 
theoretical skin concentration of parabens was much higher than the observed skin concentration. This 
lack of a 1:1 relationship is due to the assumption that the skin is one homogenous layer. 
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Figure 8. Relationship between theoretical and observed steady-state hairless rat skin 
concentration of parabens. Normalized data were used (see Figure 7). One-layered diffusion 
membrane model was used to obtain theoretical steady-state membrane concentration of 
parabens. ●: 10 mM MP; ◊: 3 mM EP; ▲: 1 mM PP; □: 0.5 mM BP. The observed data 
represent the mean ± S.D. (n = 5–11). The obtained line was very different from 1:1 
correlation. P values were listed below. 
Parabens P Value (×10−6 cm/s) 
MP 2.03 ± 0.483 
EP 3.15 ± 0.552 
PP 3.84 ± 0.217 
BP 1.26 ± 0.512 
 
 
 
 
 
 
Figure 9 illustrates the relationship between K and silicone membrane and rat skin. The two  
K values have a linear relation. These results suggest that the skin concentration of parabens cannot be 
easily predicted by calculating the skin permeation profiles because of the simple assumption about the 
skin membrane. 
Figure 9. Relationship between K to silicone membrane and K to rat skin (one-layered 
diffusion model). ●: 10 mM MP; ◊: 3 mM EP; ▲: 1 mM PP; □: 0.5 mM BP. Each data point 
represents the mean ± S.E. (n = 4–8 in silicone membrane data and 5–11 in rat skin data). 
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4.3. Simulation of Skin Concentration of Parabens 
We then assumed that skin consists of two diffusion layers, of which the first layer is the stratum 
corneum and the second layer is the viable epidermis and dermis. The partition coefficient from the 
vehicle to the stratum corneum and that to the viable epidermis and dermis was obtained from 
permeation data through full-thickness and stripped skin. 
First, the stripped skin permeability of parabens was measured. Figure 10a,b show raw and 
normalized permeation profiles through stripped skin. Tape stripping of the stratum corneum increased 
the skin permeation of parabens, especially hydrophilic parabens such as MP. 
Figure 10. Time course of the cumulative amount of parabens that permeated hairless rat 
stripped skin. (a) raw data; (b) normalized data. ●: 10 mM MP; ◊: 3 mM EP; ▲: 1 mM PP; 
□: 0.5 mM BP. Each data point represents the mean ± S.E. (n = 3). 
 
Figure 11 shows the relation between the observed and calculated skin concentrations. The figure 
also summarizes the obtained permeation parameters of parabens in the legend. The theoretical values 
are close to the observed values, although little difference was found, which may be dependent on the 
process of washing the skin surface. The two-layered model predicts the skin concentration of 
parabens from skin permeation experiments much better than the one-layered model of hairless rat 
skin. Animal skin has appendages such as hair follicles and sweat ducts as additional permeation 
pathways to the primary permeation pathway, the stratum corneum [21]. The hydrophilic pathway as 
well as the lipophillic pathway play a role in the overall skin permeation of several compounds. The 
contribution of appendages and the hydrophilic pathway must be taken into account to better predict 
the skin concentration of materials from skin permeation profiles. 
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Figure 11. Relationship between theoretical and observed Css in hairless rat skin. 
Normalized data were used (see Figure 7). Two-layered diffusion membrane model was 
used to obtain theoretical steady-state skin concentration of parabens. Symbols: as in 
Figure 3. The observed data represent the mean ± S.D. (n = 3–8). Almost 1:1 correlation 
was found. Ptot and Pved values were listed below. 
Parabens Ptot Value (×10−6 cm/s) Pved Value (×10−5 cm/s) 
MP 2.46 ± 0.483 1.85 ± 0.239 
EP 5.73 ± 0.552 1.96 ± 0.3 
PP 3.18 ± 0.032 0.628 ± 0.067 
BP 1.25 ± 0.431 0.348 ± 0.179 
 
 
 
 
 
 
Figure 12 shows the relationship between the theoretical concentration of parabens in the silicone 
membrane and the normalized observed concentration of parabens in hairless rat skin. The very high 
correlation coefficient, 0.997, between them suggests the high predictability of the skin concentration 
of parabens using silicone membrane permeation experiments. 
Figure 12. Relationship between theoretical Css in silicone membrane/donor concentration 
and observed Css in rat skin/donor concentration. ●: 10 mM MP; ◊: 3 mM EP; ▲: 1 mM PP; 
□: 0.5 mM BP. Each data point represents the mean ± S.D. (n = 3–8). 
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We supposed a homogenous one-layered model for the silicone membrane and two-layered model 
consisted of stratum corneum and the following layer for the rat skin. Although these membrane 
models were different, their concentration-distance profiles and theoretical concentrations of drug or 
cosmetic ingredient in both the membranes can be expressed only by physical diffusion model. Thus, 
membrane concentration in the two-layered diffusion model can be easily replaced by that in the  
one-layered model using a mathematical approach. This is a reason why diffusion profile through 
silicone membrane is useful to predict the skin concentration of drugs or cosmetic ingredients. 
In the near future, we plan to use broad compounds other than parabens, which is a simple series of 
compounds. We also plan to use several topical formulations, such as creams, ointments and patches. A 
silicone membrane permeation study using broad compounds from several formulations will produce a 
monogram of how to estimate the skin concentration of materials. All topical drugs have different 
target sites in skin tissues. Distribution of the skin concentration must be clarified from the shallow to 
deep layer in the near future. Since this is an alternative method to animal studies, it can be easily used 
by pharmaceutical and cosmetic companies to estimate the skin concentration after applying topical 
drug formulations and cosmetics. 
5. Conclusions 
The drug concentration in the silicone membrane and animal skin can be easily predicted using 
diffusion equations and membrane permeation data. This method can be applied to the design of 
cosmetic and topical pharmaceutical formulations. A silicone membrane can be used as an alternative 
membrane to animal skin. 
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